Supply Chain

Managing supplies is a crucial part of moving medical products from the manufacturer to patient’s bedside. Efficient supply chains can reduce healthcare costs and make medical devices more affordable for patients and health systems. This news page includes content on supply shortages, inventory management, and procurement practices.

RSS icon

AHRMM: Communication, collaboration key to supply chain success

BOSTONTo hear Michael Bohon tell it, more than a few C-level hospital leaders think they have a problem with their supply chainand theyre wrong.

AHRMM: C-suite execs confirm supply chain impacts hospital performance

BOSTONHospital leaders agree that supply chain management impacts operational performance and clinical performance, according to survey results presented Aug. 8 at the 2011 Association for Healthcare Resource & Materials Management (AHRMM) annual conference, and now is the time for supply chain leaders to act, noted presenter Jamie C. Kowalski, CEO of the Jamie C. Kowalski consulting firm.

AHRMM: Paradigm shift first step in supply chain improvement

BOSTONTo leverage the role of the supply chain from just order-takers to strategic planners, hospital leaders and members of the C-suite need to undergo a change in mindset, according to John R. McMillen, director of supply chain at Childrens Healthcare of Atlanta, during an Aug. 8 presentation at the 2011 Association for Healthcare Resource & Material Management (AHRMM) annual conference.

Displaying 105 - 107 of 107

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.